United Health Products, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UEEC research report →
Price Chart
About the company
Based in Henderson, Nevada, United Health Products, Inc. , established in 1997, focuses on the creation, production, and distribution of hemostatic gauze solutions throughout the United States. This company primarily caters to the healthcare and wound management industries.
- CEO
- Brian D. Thom
- IPO
- 2007
- Employees
- 7
- HQ
- Mount Laurel, NV, US
Get TickerSpark's AI analysis on UEEC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.20M
- P/E
- -7.82
- PEG
- -0.12
- P/S
- 0.00
- P/B
- -2.52
- EV/EBITDA
- -14.22
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 35.90%
- ROIC
- 44.06%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-3,240+30.1%
- Op Income
- $-2,255,474
- Net Income
- $-2,669,348-33.4%
- EPS
- $-0.01-28.4%
- OCF Growth
- +0.7%
- FCF Growth
- +0.7%
- 52W High
- $0.12
- 52W Low
- $0.03
- 50D MA
- $0.05
- 200D MA
- $0.06
- Beta
- -0.26
- RSI (14)
- 42
- Avg Volume
- 160.88K
No earnings-call transcripts are available for UEEC yet.
- Free Float
- 88.8%
- Shares Outstanding
- 260.39M
- Float Shares
- 231.31M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for UEEC, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Buy | Feb 14, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 8, 25 | Thom Brian David | buy | 32,000 |
| Mar 31, 25 | Thom Brian David | buy | 18,000 |
| May 12, 23 | Thom Brian David | sell | 300,000 |
| Apr 17, 23 | Thom Brian David | other | 309,375 |
| Dec 31, 22 | Heaton Kristofer | other | 0 |
| Jan 13, 23 | Thom Brian David | other | 225,000 |
| Dec 31, 22 | Thom Brian David | other | 0 |
| Sep 16, 22 | Thom Brian David | other | 150,000 |
| Jun 2, 22 | Thom Brian David | sell | 127,100 |
| Jun 3, 22 | Thom Brian David | sell | 56,055 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our UEEC coverage
Recent articles, reports, and earnings notes.
No research on UEEC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UEEC report →United Health Products (OTCMKTS:UEEC) and QuidelOrtho (NASDAQ:QDEL) Financial Comparison
defenseworld.net · Apr 23
Head-To-Head Comparison: Insulet (NASDAQ:PODD) vs. United Health Products (OTCMKTS:UEEC)
defenseworld.net · Mar 1
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
globenewswire.com · Sep 16
Elucid's PlaqueIQ™ Image Analysis Software Now Covered by United Healthcare
businesswire.com · Aug 11
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
globenewswire.com · May 12
United Health Products Provides Update on Clinical Study Process
globenewswire.com · Dec 2
United Health Products Submits Response Letter to FDA
globenewswire.com · Aug 19
United Health Products Submits Full FDA PMA Application
globenewswire.com · Mar 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.